-
Fierce Biotech3 weeks ago
Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
Novartis has struck a deal to buy Synnovation Therapeutics’ pan-mutant‑selective PI3Kα inhibitor for $2 billion upfront, securing an asset that could defend its breast cancer franchise...
-
Fierce Biotech3 weeks ago
Gilead turns down chance to build on Assembly’s phase 1-stage HBV antiviral
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner on other assets.
-
Fierce Biotech3 weeks ago
Gilead turns down chance to build on Assembly’s phase 1-stage HBV antiviral
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner on other assets.
-
GEN – Genetic Engineering & Biotechnology News3 weeks ago
Metastasis Slowed by Targeting Lipid Metabolism in Healthy Lung Cells
Lung metastasis remains one of the turning points in cancer progression, in part because the lung provides a uniquely supportive niche for incoming tumor cells. Among...
-
GEN – Genetic Engineering & Biotechnology News3 weeks ago
Modifying T Cell Receptor Improves Targeted Cancer Therapy
Much of the challenge in developing cancer therapies is determining methods to improve the effectiveness of the immune system’s ability to identify and kill cancer cells....
-
GEN – Genetic Engineering & Biotechnology News3 weeks agoComputational Model Predicts Telomere Length from Images of Routine Histopathology Slides
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a new computational tool, TLPath, that can infer changes occurring at the ends of chromosomes—the telomeres—by...
-
STAT News – Biotech3 weeks agoSTAT+: Political influence ‘a serious problem’ for FDA under Trump, former commissioner says
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly. At...
-
GEN – Genetic Engineering & Biotechnology News3 weeks ago
Bio-Sourcing and Tiny Cargo Partner on Orally Delivered mAbs Using Goat Milk Exosomes
Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat milk-derived extracellular vesicles...
-
STAT News – Biotech3 weeks agoJudge will rule against Kennedy’s declaration on gender-affirming care
A U.S. district judge in Oregon said he will vacate a declaration made late last year by health secretary Robert F. Kennedy Jr. that asserted gender-affirming...
-
Endpoints News3 weeks ago
Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refuted
ACIP is being broken up. No it’s not. On Thursday afternoon, an outspoken member of the CDC’s Advisory Committee on Immunization Practices claimed that the vaccine...
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
